Contingency Management for Smoking Cessation
Randomized Trial of a Contingency Management Smoking Cessation Intervention for Homeless Adults
2 other identifiers
interventional
83
1 country
2
Brief Summary
The prevalence of smoking in the homeless population (70%) is over 4 times that of the general population (15%). Homeless adults have not experienced similar declines in tobacco use as the general population has over the past three decades. Homeless adults are interested in smoking cessation and make quit attempts, but are less successful in quitting smoking than the general population. Trials of group behavioral counseling and pharmacotherapy for smoking cessation have not led to substantial long-term abstinence (i.e., abstinence for 6 months or more), suggesting that these interventions alone are insufficient to improve quit rates among homeless adults. Many homeless adults seek health care in safety net clinics; these clinics could bring cessation interventions to scale. Contingency management is a powerful behavior change intervention that reinforces positive health behaviors through the provision of modest incentives (e.g., cash). In this pilot randomized controlled trial, the investigator will test the feasibility and acceptability of a contingency management intervention that provides incentives for smoking cessation for people experiencing homelessness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2021
CompletedFirst Posted
Study publicly available on registry
July 29, 2021
CompletedStudy Start
First participant enrolled
November 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedDecember 5, 2024
December 1, 2024
2.6 years
July 23, 2021
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Proportion of participants who achieve point prevalence abstinence
The proportion of participants who achieve biochemically-verified 7-day point prevalence abstinence defined as participants (1) reporting not smoking a single cigarette in the past seven days, not even a puff; (2) having carbon monoxide (CO) levels \<=5 parts per million (ppm), and (3) urinary anatabine/anabasine assay levels \< 2 nanograms per milliliter (ng/ml).
6 months
Median number of carbon monoxide (CO) negative samples
The total number of negative CO specimen samples collected throughout the first 6 months of the program will be reported with 24 maximum possible number of samples per person.
6 months
Median total number of counseling sessions attended
The number of counseling sessions attended per person will will recorded with a maximum of 5 sessions total.
6 months
Proportion of the sample retained as a result of retention procedures over time
The proportion of participants who choose to attend cessation sessions visits at 2 weeks, 1 month, 3 months, 6 months, and 12 months. A participant will be considered lost to follow-up and censored on their last visits if the participants have failed to return for a scheduled visit and the study staff are unable to contact the participant after at least 3 attempts.
Up to 12 months
Secondary Outcomes (3)
Proportion of participants who achieve point prevalence abstinence
3 months
Proportion of participants who achieve point prevalence abstinence
12 months
Proportion of participants who achieve prolonged abstinence over time
Up to 6 months
Study Arms (2)
Contingency Management (CM)
EXPERIMENTALIn addition to receiving usual cessation care at the Tom Waddell Urban Health Center (TWUHC), CM intervention participants with CO-verified abstinence will obtain a CM incentive payment, via gift cards and/or cash redeemable in national retail chains.
Control Group
OTHERParticipants who choose to attend smoking cessation in the usual care setting at TWUHC will receive a basic $5 payment for attending each study visit.
Interventions
Increasing incentive payment for abstinent participant
Eligibility Criteria
You may qualify if:
- Are 18 years or older
- Engaged in care at the Tom Waddell Urban Health Center (TWUHC)
- Meet criteria for homelessness as defined by the Homeless Emergency Assistance and Rapid Transition to Housing Act
- Are current smokers (smoked at least 100 cigarettes in lifetime, smoked daily in the past 7 days and at least 5 cigarettes per day, verified by expired Carbon Monoxide (CO) \>= 8 parts per million (ppm))
- Have an intention to quit smoking within the next six months
- Are attending on-site smoking cessation counseling provided by the behavioral counselors
- Are English proficient
- Are able to provide informed consent. Patients who are interested in participating but not enrolled in counseling services will be encouraged to engage in counseling sessions at the time of enrollment.
You may not qualify if:
- \. Are unable to take nicotine replacement therapy (e.g., pregnancy or myocardial infarction (MI) within the past 2 weeks)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The Richard H. Fine's People's Clinic
San Francisco, California, 94110, United States
University of California, San Francisco
San Francisco, California, 94143, United States
Related Publications (1)
Molina MF, Hall SM, Stitzer M, Kushel M, Chakravarty D, Vijayaraghavan M. Contingency management to promote smoking cessation in people experiencing homelessness: Leveraging the electronic health record in a pilot, pragmatic randomized controlled trial. PLoS One. 2022 Dec 16;17(12):e0278870. doi: 10.1371/journal.pone.0278870. eCollection 2022.
PMID: 36525405DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maya Vijayaraghavan, MD, MAS
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2021
First Posted
July 29, 2021
Study Start
November 9, 2021
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
December 5, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share